🔎 Trials Near Me

Akèy › Maladi Crohn › Missouri › Independence

Etid klinik pou Maladi Crohn nan Independence, MO

8 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Independence (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Ap rekriteFaz 3
  • BVL Research - Kansas ( Site 0292), Liberty · 11 mi lwen
Tout laj · Tout sèks · Mizajou Oct 2, 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Ap rekriteFaz 3
  • BVL Research - Kansas ( Site 5099), Liberty · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Ap rekriteFaz 2
  • Bvl Research /ID# 265870, Liberty · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • BVL Clinical Research, Liberty · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT06233461

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • BVL Clinical Research-Site Number: 8400005, Liberty · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 3
  • BVL Clinical Research-Site Number: 8400005, Liberty · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Ap rekriteFaz 4
  • BVL Clinical Research, Liberty · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06045754

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Liberty · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Maladi Crohn nan lòt vil

Lòt etid nan Independence

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.